-
Mashup Score: 0Blood & Cancer | MDedge - 4 year(s) ago
A twice-weekly podcast bringing you the latest news on Tuesdays and interviews with hematology/oncology experts on Thursdays. …
Source: www.mdedge.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Blood & Cancer | MDedge - 4 year(s) ago
A twice-weekly podcast bringing you the latest news on Tuesdays and interviews with hematology/oncology experts on Thursdays. …
Source: www.mdedge.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Listen to the Best of ASCO 2020 on MDedge’s Blood & Cancer podcast with @davidhenrymd, and @Nick_Andrews__. https://t.co/YtIfOTB8u8 #ASCO2020 #LexPodcast #MDedge https://t.co/SNKNtaksLe
-
-
Mashup Score: 0Blood & Cancer | MDedge - 4 year(s) ago
A twice-weekly podcast bringing you the latest news on Tuesdays and interviews with hematology/oncology experts on Thursdays. …
Source: www.mdedge.comCategories: General Medicine News, Latest HeadlinesTweet-
Listen to the Best of ASCO 2020 on MDedge’s Blood & Cancer podcast with @davidhenrymd, and @Nick_Andrews__. https://t.co/wFGCT8RNUh #ASCO2020 #LexPodcast #MDedge https://t.co/gORpibQA9Y
-
-
Mashup Score: 0Blood & Cancer | MDedge - 4 year(s) ago
A twice-weekly podcast bringing you the latest news on Tuesdays and interviews with hematology/oncology experts on Thursdays. …
Source: www.mdedge.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Listen to the Best of ASCO 2020 on MDedge’s Blood & Cancer podcast with @davidhenrymd, and @Nick_Andrews__. https://t.co/whKw8PXw2q #ASCO2020 #LexPodcast #MDedge https://t.co/XxwPtsv3OX
-
-
Mashup Score: 2'Abysmal' Student Makes the Grade as Oncologist - 4 year(s) ago
Kurt Oettel, MD, had a poor academic performance as an undergraduate and a long, hard road to med school acceptance.
Source: MedscapeCategories: General Medicine News, Latest HeadlinesTweet-
From rock bottom student to rock star doc and #ASCO2020 speaker. https://t.co/ckxusnNLG4
-
-
Mashup Score: 10'Abysmal' Student Makes the Grade as Oncologist - 4 year(s) ago
Kurt Oettel, MD, had a poor academic performance as an undergraduate and a long, hard road to med school acceptance.
Source: MedscapeCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
How this unpromising #premed student turned accomplished doctor + #ASCO2020 speaker. https://t.co/0Z86Vn2b1l
-
-
Mashup Score: 1
An abstract is unavailable.
Source: LWWCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Virtual #ASCO2020 Meeting: Insights from Dr. George Sledge, Jr. https://t.co/syrB3YOMPb #cancertreatment #research #medtwitter #tuesdaythoughts https://t.co/Vo7PZZbLJg
-
-
Mashup Score: 1Adding Pevonedistat to Azacitidine Shows Promise in MDS, AML - 4 year(s) ago
No difference in adverse events between the combination and monotherapy, says Mikkael Sekeres, MD
Source: www.medpagetoday.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
In this #video, @MikkaelSekeres, MD, director of the Leukemia Program at the Cleveland Clinic in Ohio, discusses the results of a study he presented at virtual #ASCO20. #ASCO2020 @ASCO #leusm https://t.co/028n0VFwTT
-
-
Mashup Score: 15-year follow-up demonstrates long-term benefit of dabrafenib/trametinib for stage 3 melanoma - 4 year(s) ago
Results presented at the recent ASCO 2020 Virtual Scientific Program demonstrate the long-term relapse-free and survival benefit of dabrafenib (Tafinlar, Novartis) and trametinib (Mekinist, Novartis) as a combination treatment following surgery in stage III BRAF V600E/K-mutant melanoma patients.
Source: Dermatology TimesCategories: Dermatology, Latest HeadlinesTweet-
Results presented at #ASCO2020 demonstrate the long-term relapse-free and survival benefit of dabrafenib (Tafinlar) and trametinib (Mekinist) as a combination treatment following surgery in stage III BRAF V600E/K-mutant melanoma patients.https://t.co/5k6f7MWn3x https://t.co/yIBO4gbkqG
-
-
Mashup Score: 0
An abstract is unavailable.
Source: LWWCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Virtual #ASCO2020 Meeting: Insights from Dr. George Sledge, Jr. https://t.co/syrB3YOMPb #cancertreatment #research #medtwitter #tuesdaythoughts https://t.co/7jrOXzniv2
-
Listen to the Best of ASCO 2020 on MDedge’s Blood & Cancer podcast with @davidhenrymd, and @Nick_Andrews__. https://t.co/sKd9ZYYf9N #ASCO2020 #LexPodcast #MDedge https://t.co/CyvpgSFswS